Frontiers in Clinical Drug Research - CNS and Neurological Disorders is an eBook series that brings updated reviews to readers interested in advances in the development of pharmaceutical agents for the treatment of central nervous system (CNS) and other nerve disorders. The scope of the eBook series covers a range of topics including the medicinal chemistry, pharmacology, molecular biology and biochemistry of contemporary molecular targets involved in neurological and CNS disorders. Reviews presented in the series are mainly focused on clinical and therapeutic aspects of novel drugs intended for these targets. Frontiers in Clinical Drug Research - CNS and Neurological Disorders is a valuable resource for pharmaceutical scientists and postgraduate students seeking updated and critical information for developing clinical trials and devising research plans in the field of neurology.
The third volume of this series features six chapters that cover a variety of topics including:
-the role of Potassium transport channels in neuroprotection against tetrahydroprotoberberines
-cannabinoids in cell therapy for CNS disorders
-AMPA Receptor Antagonists
-therapeutic intervention in polyglutamine ataxias
-nutritional therapies in neurology practice